[Studies on granulocyte-specific antinuclear factor granulocyte-specific antinuclear factor associated with propylthiouracil in patient with hyperthyroidism (author's transl)].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The influence of pre-treatment with a variety of agents on the uptake of 75Se-selenomethionine by the rat pancreas has been studied. The agents ranged from thyroid hormones to protein synthesis inhibitors but out of 16 tested, only propylthiouracyl (50 mg/kg i.p. administered for 3 days prior to 75Se-methionine injection) resulted in a significant increase in the pancreatic uptake (17%) and in the pancreas liver concentration ratio (25%). Seven of the agents resulted in significant reductions in the pancreas/liver concentration ratios. No significant effects were produced by the addition of carrier methionine or selenomethionine (in the range 10-250 micrograms/kg body weight) to the injected radiopharmaceutical. It was concluded that many factors may influence the uptake, but that the interrelationship of hypothalamus, pituitary and pancreas is of particular interest.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.